Novo Holdings CEO Kasim Kutay says China has “really moved up the value chain” in healthcare. “We’ve seen many others investing in China because of the leap that they’re taking from an innovation and technology perspective,” Kutay says on Bloomberg Television. Novo Holdings is the owner of Novo Nordisk, famous for its diabetes medicine Ozempic and obesity treatment Wegovy. (Source: Bloomberg)
Visited 1 times, 1 visit(s) today
